Compounds > n-n-propyl-n-n-butyl-beta-dopamine
Page last updated: 2024-09-04

n-n-propyl-n-n-butyl-beta-dopamine and sk&f-38393

n-n-propyl-n-n-butyl-beta-dopamine has been researched along with sk&f-38393 in 1 studies

Compound Research Comparison

Studies
(n-n-propyl-n-n-butyl-beta-dopamine)		Trials
(n-n-propyl-n-n-butyl-beta-dopamine)		Recent Studies (post-2010)
(n-n-propyl-n-n-butyl-beta-dopamine)		Studies
(sk&f-38393)		Trials
(sk&f-38393)		Recent Studies (post-2010) (sk&f-38393)
17102,01229242

Protein Interaction Comparison

ProteinTaxonomyn-n-propyl-n-n-butyl-beta-dopamine (IC50)sk&f-38393 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 22.8
DRattus norvegicus (Norway rat)0.19

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ginos, JZ; Goldberg, LI; Woolverton, WL1

Other Studies

1 other study(ies) available for n-n-propyl-n-n-butyl-beta-dopamine and sk&f-38393

ArticleYear
Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 230, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dextroamphetamine; Dopamine; Female; Macaca mulatta; Male; Motor Activity; Piribedil; Receptors, Dopamine; Self Administration

1984